Astera Labs (NASDAQ:ALAB) Shares Down 1.4% After Analyst Downgrade

Astera Labs, Inc. (NASDAQ:ALAB) traded down 1.4% during trading on Friday after Northland Securities downgraded the stock from an outperform rating to a market perform rating. The company traded as low as $326.25 and last traded at $342.21. 4,059,810 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 5,191,552 shares. The stock had previously closed at $347.05.

Several other research analysts have also recently issued reports on ALAB. Susquehanna upped their price target on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Morgan Stanley upped their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Ten investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Hold” and an average target price of $348.33.

Insiders Place Their Bets

In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 396,059 shares of company stock worth $122,605,660 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, which it describes as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The product family includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers designed for AI infrastructure. The launch expands ALAB’s addressable market and strengthens its positioning in high-speed connectivity for AI systems. Astera Labs Announces Aries 7
• Positive Sentiment: Analysts view Aries 7 as part of Astera Labs’ broader push to benefit from surging AI connectivity demand. The portfolio could help ALAB compete more directly with Marvell Technology and Credo Technology, while its optical products may give the company additional exposure to next-generation AI data-center architectures. ALAB Expands PCIe Portfolio With Aries 7
• Neutral Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business supported the broader AI-connectivity investment theme and highlighted potential demand for companies such as ALAB. However, the coverage also noted Astera Labs’ reliance on a limited number of major customers and its elevated valuation, increasing execution risk. Marvell Says Connecting AI Chips Could Be a $37 Billion Business
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” signaling reduced near-term upside after the stock’s substantial rally.
• Negative Sentiment: Jim Cramer said he likes Astera Labs’ business but believes the shares are too expensive. That warning reinforces valuation concerns, with the stock trading at a very high earnings multiple despite strong growth expectations. Jim Cramer Likes This Stock but Has a Problem With the Price

Institutional Investors Weigh In On Astera Labs

A number of institutional investors have recently bought and sold shares of ALAB. BlackRock Inc. purchased a new position in Astera Labs during the 2nd quarter valued at about $6,609,581,000. Atreides Management LP boosted its holdings in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Van ECK Associates Corp boosted its holdings in shares of Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after purchasing an additional 373,545 shares during the period. Bank of America Corp DE purchased a new position in Astera Labs during the second quarter valued at approximately $1,061,791,000. Finally, Fred Alger Management LLC grew its position in Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Performance

The stock has a market cap of $59.37 billion, a price-to-earnings ratio of 169.41 and a beta of 3.68. The company’s 50 day simple moving average is $316.82 and its two-hundred day simple moving average is $290.03.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.